A local tournament contains a vertex whose out-arcs are g-pancyclic

Shengjia Li,Wei Meng,Yubao Guo

Abstract:

What problem does this paper attempt to address?

Potential Immunohistochemical Biomarkers for Grading Oral Dysplasia: A Literature Review

Jakub Zdrojewski,Monika Nowak,Kacper Nijakowski,Jakub Jankowski,Andrea Scribante,Simone Gallo,Maurizio Pascadopoli,Anna Surdacka

DOI: https://doi.org/10.3390/biomedicines12030577

IF: 4.757

2024-03-06

Biomedicines

Abstract:Oral cancer is a prevalent global health issue, with significant morbidity and mortality rates. Despite available preventive measures, it remains one of the most common cancers, emphasising the need for improved diagnostic and prognostic tools. This review focuses on oral potentially malignant disorders (OPMDs), precursors to oral cancer, specifically emphasising oral epithelial dysplasia (OED). The World Health Organisation (WHO) provides a three-tier grading system for OED, and recent updates have expanded the criteria to enhance diagnostic precision. In the prognostic evaluation of OED, histological grading is presently regarded as the gold standard; however, its subjectivity and unreliability in anticipating malignant transformation or recurrence pose notable limitations. The primary objective is to investigate whether specific immunohistochemical biomarkers can enhance OED grading assessment according to the WHO classification. Biomarkers exhibit significant potential for comprehensive cancer risk evaluation, early detection, diagnosis, prognosis, and treatment optimisation. Technological advancements, including sequencing and nanotechnology, have expanded detection capabilities. Some analysed biomarkers are most frequently chosen, such as p53, Ki-67, cadherins/catenins, and other proteins used to differentiate OED grades. However, further research is needed to confirm these findings and discover new potential biomarkers for precise dysplasia grading and minimally invasive assessment of the risk of malignant transformation.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy
Recommendations for Research to Develop a Patient‐Centered Clinical Follow‐Up Protocol for Oral Epithelial Dysplasia

Pelin Güneri,Gaye Bolukbasi,Betul Ilhan,Joel B. Epstein,Saman Warnakulasuriya

DOI: https://doi.org/10.1002/hed.28001

2024-11-25

Head & Neck

Abstract:Oral epithelial dysplasia (OED) is the primary histological marker for assessing the progression of oral potentially malignant disorders (OPMDs) to cancer. Despite challenges in grading and low inter‐pathologist reproducibility, OED severity remains the key predictor of malignant transformation. However, globally accepted guidelines for OED monitoring are lacking, despite calls for individualized management based on host and lesion characteristics. The proposed research protocol involves acquiring high‐quality intraoral images, assessing oral hygiene and periodontal status, eliminating chronic mechanical irritation and Candida infections, and applying adjunctive diagnostic methods like toluidine blue staining, optical evaluation, and brush cytology. Tailored follow‐up regimens based on individual risk assessments are emphasized, with frequent monitoring for high‐grade dysplasia or patients at higher risk of progression. Therefore, effective OED management should consider the patient's immune status, dietary habits, and oral microbiota, aiming to develop personalized treatment strategies that optimize patient‐centered care.

surgery,otorhinolaryngology
Recent trends in predictive biomarkers for determining malignant potential of oral potentially malignant disorders

Gargi S Sarode,Sachin C Sarode,Nikunj Maniyar,Nilesh Sharma,Sujata Yerwadekar,Shankargouda Patil

DOI: https://doi.org/10.4081/oncol.2019.424

2019-09-10

Abstract:Despite of the tremendous advancements in the field of cancer prevention, detection and treatment, the overall prognosis of oral squamous cell carcinoma (OSCC) still remains poor. This can be partly imparted to the lack of early detection of oral potentially malignant disorders (OPMDs), especially those at a higher risk of progression into OSCC. Over years, various specific and non-specific markers have been introduced that could predict the malignant transformation of OPMDs; however detail information on these OPMD markers in a concise manner is lacking. Moreover, their use on daily clinical basis still remains questionable. With continuous research in the field of cytology and genomics, several contemporary biomarkers have been discovered that are not yet foregrounded and proved to be more promising than those used conventionally. Here, in the present paper, we overview several recently concluded predictive biomarkers with special emphasis on their role in molecular pathogenesis of OSCC transformation. These markers can be used for risk assessment of malignant transformation in patients with OPMDs as well as for prophylactic conciliation and fair management of the high-risk OPMD patient group.
The Impact of Histopathological Features on the Prognosis of Oral Squamous Cell Carcinoma: A Comprehensive Review and Meta-Analysis

Eder da Silva Dolens,Mauricio Rocha Dourado,Alhadi Almangush,Tuula A. Salo,Clarissa Araujo Gurgel Rocha,Sabrina Daniela da Silva,Peter A. Brennan,Ricardo D. Coletta

DOI: https://doi.org/10.3389/fonc.2021.784924

IF: 4.7

2021-11-10

Frontiers in Oncology

Abstract:Objective Over many decades, studies on histopathological features have not only presented high-level evidence of contribution for treatment directions and prognosis of oral squamous cell carcinoma (OSCC) but also provided inconsistencies, making clinical application difficult. The 8th TNM staging system of OSCC has acknowledged the importance of some histopathological features, by incorporating depth of invasion (DOI) to T category and extranodal extension (ENE) to N category. The aim of this systematic review with meta-analysis is to determine the most clinically relevant histopathological features for risk assessment and treatment planning of OSCC and to elucidate gaps in the literature. Methods A systematic review was conducted using PRISMA guidelines, and the eligibility criteria were based on population, exposure, comparison, outcome, and study type (PECOS). PubMed, Cochrane, Scopus, and Web of Science were searched for articles exploring the impact of histopathological features on OSCC outcomes with Cox multivariate analysis. Pooled data were subjected to an inverse variance method with random effects or fixed effect model, and the risk of bias was evaluated using quality in prognosis studies (QUIPS). Quality of evidence was assessed with the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria. Results The study included 172 articles published from 1999 to 2021. Meta-analyses confirmed the prognostic potential of DOI, ENE, perineural invasion, lymphovascular invasion, and involvement of the surgical margins and brought promising results for the association of bone invasion, tumor thickness, and pattern of invasion with increased risk for poor survival. Although with a small number of studies, the results also revealed a clinical significance of tumor budding and tumor-stroma ratio on predicted survival of patients with OSCC. Most of the studies were considered with low or moderate risk of bias, and the certainty in evidence varied from very low to high. Conclusion Our results confirm the potential prognostic usefulness of many histopathological features and highlight the promising results of others; however, further studies are advised to apply consistent designs, filling in the literature gaps to the pertinence of histopathological markers for OSCC prognosis. Systematic Review Registration International Prospective Register of Systematic Reviews (PROSPERO), identifier CRD42020219630.

oncology
Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases

Wei Liu,Zhe‐Xuan Bao,Lin‐Jun Shi,Guo‐Yao Tang,Zeng‐Tong Zhou,Zhe-Xuan Bao,Lin-Jun Shi,Guo-Yao Tang,Zeng-Tong Zhou

DOI: https://doi.org/10.1111/j.1365-2559.2011.03938.x

2011-09-14

Histopathology

Abstract:AIMS: To explore the usefulness of a new binary system of grading dysplasia proposed by the World Health Organization and to identify significant risk factors for malignant transformation in a long-term follow-up cohort of patients with oral epithelial dysplasia.METHODS AND RESULTS: A total of 138 patients with histologically confirmed oral dysplasia between 1978 and 2008 were reviewed retrospectively in our department. The mean follow-up period was 5.1 years. Of these dysplasias, 37 (26.8%) developed into cancer, with a mean duration of 4.6 years. Cox regression analysis revealed that high-grade dysplasia was an independent risk factor for transition, but age, gender, lesion site, diet habit, smoking and alcohol intake were not risk factors. High-grade dysplasia was associated with a 2.78-fold (95% confidence interval 1.44-5.38; P = 0.002) increased risk of transition, as compared with low-grade dysplasia. Consistently, high-grade dysplasia had a significantly higher incidence of malignancy than low-grade dysplasia by Kaplan-Meier analysis (log-rank test, P = 0.001).CONCLUSIONS: The utilization of high-grade dysplasia as a significant indicator for evaluating malignant transformation risk in patients with potentially malignant lesions is suggested; this may be helpful to guide treatment selection in clinical practice.

pathology,cell biology
An Update on the Use of Artificial Intelligence in Digital Pathology for Oral Epithelial Dysplasia Research

Shahd A Alajaji,Zaid H Khoury,Maryam Jessri,James J Sciubba,Ahmed S Sultan

DOI: https://doi.org/10.1007/s12105-024-01643-4

2024-05-10

Abstract:Introduction: Oral epithelial dysplasia (OED) is a precancerous histopathological finding which is considered the most important prognostic indicator for determining the risk of malignant transformation into oral squamous cell carcinoma (OSCC). The gold standard for diagnosis and grading of OED is through histopathological examination, which is subject to inter- and intra-observer variability, impacting accurate diagnosis and prognosis. The aim of this review article is to examine the current advances in digital pathology for artificial intelligence (AI) applications used for OED diagnosis. Materials and methods: We included studies that used AI for diagnosis, grading, or prognosis of OED on histopathology images or intraoral clinical images. Studies utilizing imaging modalities other than routine light microscopy (e.g., scanning electron microscopy), or immunohistochemistry-stained histology slides, or immunofluorescence were excluded from the study. Studies not focusing on oral dysplasia grading and diagnosis, e.g., to discriminate OSCC from normal epithelial tissue were also excluded. Results: A total of 24 studies were included in this review. Nineteen studies utilized deep learning (DL) convolutional neural networks for histopathological OED analysis, and 4 used machine learning (ML) models. Studies were summarized by AI method, main study outcomes, predictive value for malignant transformation, strengths, and limitations. Conclusion: ML/DL studies for OED grading and prediction of malignant transformation are emerging as promising adjunctive tools in the field of digital pathology. These adjunctive objective tools can ultimately aid the pathologist in more accurate diagnosis and prognosis prediction. However, further supportive studies that focus on generalization, explainable decisions, and prognosis prediction are needed.
Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis

Shahnawaz Khijmatgar,Josh Yong,Nicole Rübsamen,Felice Lorusso,Pooja Rai,Niccolo Cenzato,Franscesca Gaffuri,Massimo Del Fabbro,Gianluca Martino Tartaglia

DOI: https://doi.org/10.1016/j.jdsr.2023.10.003

IF: 6.468

2023-12-22

Japanese Dental Science Review

Abstract:Oral cancer became a very common condition. WHO estimates that there are 4 cases of lip and oral cavity cancer for every 100,000 people worldwide. The early diagnosis of cancers is currently a top focus in the health sector. Recent systematic reviews and meta-analyses have identified promising biomarkers for early detection in several original research investigations. However, it is still unclear the quality of these evidence and which biomarker performs the best in terms of early detection. Therefore, the objective was, to map the methodological and reporting quality of available oral squamous cell carcinoma (OSCC) or head/neck squamous cell carcinoma (HNSCC) systematic reviews and meta-analysis. Secondly, to evaluate diagnostic accuracy of salivary biomarkers for common craniofacial cancers and to compare the diagnostic value of different salivary biomarkers. PubMed, Scopus, Web of Science, Embase and Cochrane Library electronic databases were used to map the methodological and reporting quality of the systematic reviews and meta-analysis conducted on the HNSCC, OSCC using the AMSTAR-2 checklist. The inclusion criteria were systematic reviews and meta-analysis published in the topic of HNSCC and OSCC biomarkers. Exclusion criteria were no animal studies; original primary studies, due to limitation of competency in other languages articles with language other than English were excluded. The sensitivity and specificity were calculated for salivary biomarkers and ranked according to network meta-analysis principles. A total of N = 5893 patients were included from four meta-analysis studies. All together, these included n = 37 primary studies. n = 94 biomarkers were pooled from these four meta-analyses and categorised into the stages at which they were detected (I-IV). In OSCC, Chemerin and MMP-9 displayed the highest sensitivity, registering 0.94 (95% CI 0.78, 1.00) and a balanced accuracy of 0.93. Phytosphingosine closely followed, with a sensitivity of 0.91 (95% CI 0.68, 0.99) and a balanced accuracy of 0.87. For HNSCC, the top three biomarkers are Actin, IL-1β Singleplex, and IL-8 ELISA. Actin leads with a sensitivity of 0.91 (95% CI 0.68–0.99), a specificity of 0.67, and an overall accuracy of 0.79. Subsequently, IL-1β Singleplex exhibits a sensitivity of 0.62 (95% CI 0.30–0.88), a specificity of 0.89, and an accuracy of 0.75, followed by IL-8 ELISA with a sensitivity of 0.81 (95% CI 0.54–0.97), a specificity of 0.59, and an accuracy of 0.70. In conclusion, there was highest sensitivity for MMP-9 and chemerin salivary biomarkers. There is need of further more studies to identify biomarkers for HNSCC and OSCC.

dentistry, oral surgery & medicine
P16 Methylation As an Early Predictor for Cancer Development from Oral Epithelial Dysplasia: A Double-blind Multicentre Prospective Study.

Hongwei Liu,Xue-wei Liu,Guangying Dong,Jing Zhou,Yang Liu,Yan Gao,Xiao-yong Liu,Liankun Gu,Zheng Sun,Dajun Deng

DOI: https://doi.org/10.1016/j.ebiom.2015.03.015

IF: 11.205

2015-01-01

EBioMedicine

Abstract:Background: Silencing of P16 through methylation and locus deletion is the most frequent early events in carcinogenesis. The aim of this study is to prospectively determine if early P16 methylation is a predictor for oral cancer development.Methods: Patients (n = 181) with mild or moderate oral epithelial dysplasia (OED) were recruited into the double blind multicentre cohort. P16 methylation was analyzed using the MethyLight assay. Progression of OEDs was monitored for a minimum 3 year follow-up period.Findings: P16 methylation-informative cases (n = 152) were enrolled in the prospective multicenter cohorts with an ultimate compliance of 96.7%. OED-derived squamous cell carcinomas were observed in 21 patients (14.3%) during the follow-up (median, 41.0 months). The cancer progression rate from the P16 methylation-positive patients was significantly increased when compared to P16 methylation-negative patients [27.1% vs 8.1%; adjusted odds ratio = 4.6; P = 0.006]. When the P16 methylation-positive criteria were used as a biomarker for early prediction of cancer development from OEDs, sensitivity and specificity of 62% and 76% were obtained, respectively.Interpretation: P16 methylation is unequivocally a marker for determining the malignant potential of OED and there is no need for further research regarding this aspect. (C) 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Transcriptional analysis highlights three distinct immune profiles of high-risk oral epithelial dysplasia

Chai Phei Gan,Bernard Kok Bang Lee,Shin Hin Lau,Thomas George Kallarakkal,Zuraiza Mohamad Zaini,Bryan Kit Weng Lye,Rosnah Binti Zain,Hans Prakash Sathasivam,Joe Poh Sheng Yeong,Natalia Savelyeva,Gareth Thomas,Christian H Ottensmeier,Hany Ariffin,Sok Ching Cheong,Kue Peng Lim

DOI: https://doi.org/10.3389/fimmu.2022.954567

2022-09-02

Abstract:Oral potentially malignant disorders (OPMD) are precursors of oral squamous cell carcinoma (OSCC), and the presence of oral epithelial dysplasia (OED) in OPMD confers an increased risk of malignant transformation. Emerging evidence has indicated a role for the immune system in OPMD disease progression; however, the underlying immune mechanisms remain elusive. In this study, we used immune signatures established from cancer to delineate the immune profiles of moderate and severe OED, which are considered high-risk OPMD. We demonstrated that moderate and severe OEDs exhibit high lymphocyte infiltration and upregulation of genes involved in both immune surveillance (major histocompatibility complex-I, T cells, B cells and cytolytic activity) and immune suppression (immune checkpoints, T regulatory cells, and tumor-associated macrophages). Notably, we identified three distinct subtypes of moderate and severe OED: immune cytotoxic, non-cytotoxic and non-immune reactive. Active immune surveillance is present in the immune cytotoxic subtype, whereas the non-cytotoxic subtype lacks CD8 immune cytotoxic response. The non-immune reactive subtype showed upregulation of genes involved in the stromal microenvironment and cell cycle. The lack of T cell infiltration and activation in the non-immune reactive subtype is due to the dysregulation of CTNNB1, PTEN and JAK2. This work suggests that moderate and severe OED that harbor the non-cytotoxic or non-immune reactive subtype are likely to progress to cancer. Overall, we showed that distinct immune responses are present in high-risk OPMD, and revealed targetable pathways that could lead to potential new approaches for non-surgical management of OED.
Longitudinal Study of Oral Precancerous Lesions: Transformation Rate and Predictive Markers for Malignancy

Duttatrayee Das,Anu Sumi Issac,Bhavani N Sangala,Aldrin Jerry,Ajit Jankar,Teerthesh Jain,Rohit Kumar Singh

DOI: https://doi.org/10.4103/jpbs.jpbs_301_24

Abstract:Background: One of the main risk factors for the occurrence of oral cancer is oral precancerous lesions (OPLs). Early management and preventive efforts depend on knowing the transformation rate and detecting predictive signs of malignancy. Methods: For 6 months, a group of 200 individuals with clinically diagnosed OPLs was followed up on in this longitudinal research. To examine biomarker expression levels and describe the lesions, examinations using immunohistochemistry, histopathology, and clinical methods were carried out. Findings: Over the course of 2 years, 200 patients with OPLs were monitored in this study. Most lesions had mild dysplasia, according to histopathological examination. The expression of many biomarkers that were correlated with the dysplasia grade were p53 (60.0%), Ki-67 (40.0%), CDKN2A (30.0%), and epidermal growth factor receptor (EGFR) (25.0%). Conclusion: In summary, this study emphasizes how crucial it is to provide patients with OPLs with individualized care plans and routine surveillance. Certain biomarkers, such EGFR, Ki-67, and p53, can be useful prognostic markers for identifying malignant transformation. To confirm these results and create tailored therapies for high-risk patients, more study is necessary.
Epigenetics in the diagnosis and prognosis of head and neck cancer: A systematic review

Isaac Lim,Jade Tan,Anneka Alam,Majdy Idrees,Peter A. Brenan,Ricardo Della Coletta,Omar Kujan

DOI: https://doi.org/10.1111/jop.13513

2024-02-07

Journal of Oral Pathology and Medicine

Abstract:Background Aberrant epigenetic modifications significantly develop and progress human malignancies including head and neck squamous cell carcinoma (HNSCC). Taking into account issues of late diagnosis and poor prognosis associated with HNSCC, this systematic review is designed to provide an up‐to‐date insight of epigenetic changes in the management of HNSCC. Methods All studies that assessed the diagnostic and prognostic utilities of epigenetic changes (DNA methylation and histone modifications) among patients diagnosed with HNSCC or oral potentially malignant disorders (OPMDs) were considered for inclusion till June 2023. Pre‐defined Medical Subject Headings terms were used to search Web of Science, Pubmed, Scopus and Embase Ovid databases. Results Twenty‐five studies were deemed eligible for inclusion with a total number of 3790 samples (2123 HNSCCs, 334 OPMDs and 1333 as controls). DNA methylation was investigated in 18 studies while the role of histone modifications was assessed in seven studies. The most investigated biomarkers among the studies were H3, DAPK and TIMP3. The diagnostic accuracy of the epigenetic biomarkers in detecting HNSCC was assessed in eight studies where the following biomarkers showed the highest area under the curve values: TIPM3, DCC, DAPK, SEPT9, SHOX9, HOXA9 and TRH. None of the studies assessed the predictability of the epigenetic biomarkers in HNSCC and OPMDs. Conclusion Although initial promising results were seen using the epigenetic biomarkers in the early detection of HNSCC, the limited number of patients and the absence of well‐designed longitudinal studies limit the clinical applicability of the outcomes.

dentistry, oral surgery & medicine,pathology
Emerging histopathologic markers in early-stage oral tongue cancer: A systematic review and meta-analysis

Amr Elseragy,Ibrahim O Bello,Awais Wahab,Ricardo D Coletta,Antti A Mäkitie,Ilmo Leivo,Alhadi Almangush,Tuula Salo

DOI: https://doi.org/10.1002/hed.27022

Abstract:Although there are many histopathologic prognosticators, grading of early oral tongue squamous cell carcinoma (OTSCC) is still based on morphological cell differentiation which has low prognostic value. Here we summarize the emerging histopathological markers showing powerful prognostic value, but are not included in pathology reports. Using PubMed, Scopus, Ovid Medline, and Web of Science databases, a systematic literature search was preformed to identify early OTSCC studies that investigated the prognostic significance of hematoxylin-eosin-based histopathologic markers. Our meta-analysis showed that tumor budding was associated with overall survival (hazard ratio [HR] 2.32; 95% CI 1.40-3.84; p < 0.01) and disease-specific survival (DSS) (1.89; 95% CI 1.13-3.15; p = 0.02). Worst pattern of invasion was associated with disease-free survival (DFS) (1.95; 95% CI 1.04-3.64; p = 0.04). Tumor-stroma ratio was also associated with DFS (1.75, 95% CI 1.24-2.48; p < 0.01) and DSS (1.69; 95% CI 1.19-2.42; p < 0.01). Tumor budding, worst pattern of invasion, and tumor-stroma ratio have a promising prognostic value in early OTSCC. The evaluation and reporting of these markers is cost-effective and can be incorporated in daily practice.
Evaluation of Metabolomics as Diagnostic Targets in Oral Squamous Cell Carcinoma: A Systematic Review

Susanth Alapati,Giulio Fortuna,Gordon Ramage,Christopher Delaney

DOI: https://doi.org/10.3390/metabo13080890

IF: 4.1

2023-07-28

Metabolites

Abstract:In recent years, high-throughput technologies have facilitated the widespread use of metabolomics to identify biomarkers and targets for oral squamous cell carcinoma (OSCC). As a result, the primary goal of this systematic review is to identify and evaluate metabolite biomarkers and their pathways for OSCC that featured consistently across studies despite methodological variations. Six electronic databases (Medline, Cochrane, Web of Science, CINAHL, ProQuest, and Embase) were reviewed for the longitudinal studies involving OSCC patients and metabolic marker analysis (in accordance with PRISMA 2020). The studies included ranged from the inception of metabolomics in OSCC (i.e., 1 January 2007) to 30 April 2023. The included studies were then assessed for their quality using the modified version of NIH quality assessment tool and QUADOMICS. Thirteen studies were included after screening 2285 studies. The majority of the studies were from South Asian regions, and metabolites were most frequently derived from saliva. Amino acids accounted for more than quarter of the detected metabolites, with glutamate and methionine being the most prominent. The top dysregulated metabolites indicated dysregulation of six significantly enriched pathways including aminoacyl-tRNA biosynthesis, glutathione metabolism and arginine biosynthesis with the false discovery rate (FDR) <0.05. Finally, this review highlights the potential of metabolomics for early diagnosis and therapeutic targeting of OSCC. However, larger studies and standardized protocols are needed to validate these findings and make them a clinical reality.

biochemistry & molecular biology
Identification of inflammatory mediators associated with metastasis of oral squamous cell carcinoma in experimental and clinical studies: systematic review

Moustafa Elhousiny,Kate Miller,Anura Ariyawadana,Alan Nimmo

DOI: https://doi.org/10.1007/s10585-019-09994-x

Abstract:Metastasis, whether regional or distant, remains the main cause of morbidity and recurrence in oral cancer. The accumulating evidence suggests that inflammatory mediators are strong drivers for cancer progression and spread. However, the precise role of these inflammatory mediators in mediating specific metastatic stage is poorly understood due to lack of integration/validation of experimental research data and the clinical trials, i.e., the data produced from research is not translated to clinical therapeutic targets. This, in turn, results in the lack of developing reliable biomarker that can be used for accurate diagnosis/prognosis of the tumour spread. We have performed a systematic review to assess the role of inflammatory mediators as potential markers for diagnosis/prognosis of oral squamous cell carcinoma (OSCC) metastasis. We carried out a systematic search the PubMed, Web of Science, Embase and Scopus databases under the guidelines for Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Australian National Health and Medical Research Council (NHMRC). Articles were divided into two groups; experimental (in-vivo) and clinical studies. The REporting recommendations for tumour MARKer prognostic studies Scale (REMARK) was used to assess the quality of the studies for the clinical search while Animal research: Reporting In-vivo experiments (ARRIVE) guidelines were used to assess the quality of the animal studies. Sixteen articles in the clinical group and four articles in the experimental group were included in the final review. We identified nine inflammatory mediators; CXCR4, CXCL12 (SDF-1), CCR7, IL-6, IL-18, CCL20 (MIP-3), CXCL1 (GRO-1), CCL3, CXCR2. This panel of inflammatory mediators can provide a framework for hypothesis testing of the potential value of these mediators in metastatic prognosis. We recommend carrying a large cohort study with data pooling for adequate assessment and testing of the inflammatory panel of mediators.
Using a Terrorist Attack to Estimate the Effect of Police on Crime

R. Di Tella,Ernesto Schargrodsky

DOI: https://doi.org/10.2139/ssrn.269401

2002-02-01

Abstract:An important challenge in the crime literature is to isolate significant causal effects of police on crime. Following a terrorist attack on the main Jewish center in the city of Buenos Aires, Argentina, in July 1994, all Jewish and Muslim institutions (including schools, synagogues, mosques, cemeteries and clubs) were given 24-hour police surveillance. Thus, this hideous event induced a geographical allocation of police forces that can be presumed exogenous in a crime regression. Using data on the location of all car thefts in three large neighborhoods before and after the terrorist attack, we find a large negative effect of observable police on crime. The effect is local, so that the costs of police presence are almost seven times larger than the benefits in terms of lower car thefts.
Artificial Intelligence Applications in Oral Cancer and Oral Dysplasia

Chi T Viet,Michael Zhang,Neeraja Dharmaraj,Grace Y Li,Alexander T Pearson,Victoria A Manon,Anupama Grandhi,Ke Xu,Bradley E Aouizerat,Simon Young

DOI: https://doi.org/10.1089/ten.TEA.2024.0096

2024-08-07

Abstract:Oral squamous cell carcinoma (OSCC) is a highly unpredictable disease with devastating mortality rates that have not changed over the past decades, in the face of advancements in treatments and biomarkers, which have improved survival for other cancers. Delays in diagnosis are frequent, leading to more disfiguring treatments and poor outcomes for patients. The clinical challenge lies in identifying those patients at the highest risk of developing OSCC. Oral epithelial dysplasia (OED) is a precursor of OSCC with highly variable behavior across patients. There is no reliable clinical, pathological, histological, or molecular biomarker to determine individual risk in OED patients. Similarly, there are no robust biomarkers to predict treatment outcomes or mortality in OSCC patients. This review aims to highlight advancements in artificial intelligence (AI)-based methods to develop predictive biomarkers of OED transformation to OSCC or predictive biomarkers of OSCC mortality and treatment response. Biomarkers such as S100A7 demonstrate promising appraisal for the risk of malignant transformation of OED. Machine learning-enhanced multiplex immunohistochemistry workflows examine immune cell patterns and organization within the tumor immune microenvironment to generate outcome predictions in immunotherapy. Deep learning (DL) is an AI-based method using an extended neural network or related architecture with multiple "hidden" layers of simulated neurons to combine simple visual features into complex patterns. DL-based digital pathology is currently being developed to assess OED and OSCC outcomes. The integration of machine learning in epigenomics aims to examine the epigenetic modification of diseases and improve our ability to detect, classify, and predict outcomes associated with epigenetic marks. Collectively, these tools showcase promising advancements in discovery and technology, which may provide a potential solution to addressing the current limitations in predicting OED transformation and OSCC behavior, both of which are clinical challenges that must be addressed in order to improve OSCC survival.
A fully automated and explainable algorithm for predicting malignant transformation in oral epithelial dysplasia

Adam J. Shephard,Raja Muhammad Saad Bashir,Hanya Mahmood,Mostafa Jahanifar,Fayyaz Minhas,Shan E. Ahmed Raza,Kris D. McCombe,Stephanie G. Craig,Jacqueline James,Jill Brooks,Paul Nankivell,Hisham Mehanna,Syed Ali Khurram,Nasir M. Rajpoot

DOI: https://doi.org/10.1038/s41698-024-00624-8

2024-06-28

npj Precision Oncology

Abstract:Abstract Oral epithelial dysplasia (OED) is a premalignant histopathological diagnosis given to lesions of the oral cavity. Its grading suffers from significant inter-/intra-observer variability, and does not reliably predict malignancy progression, potentially leading to suboptimal treatment decisions. To address this, we developed an artificial intelligence (AI) algorithm, that assigns an Oral Malignant Transformation (OMT) risk score based on the Haematoxylin and Eosin (H&E) stained whole slide images (WSIs). Our AI pipeline leverages an in-house segmentation model to detect and segment both nuclei and epithelium. Subsequently, a shallow neural network utilises interpretable morphological and spatial features, emulating histological markers, to predict progression. We conducted internal cross-validation on our development cohort (Sheffield; n = 193 cases) and independent validation on two external cohorts (Birmingham and Belfast; n = 89 cases). On external validation, the proposed OMTscore achieved an AUROC = 0.75 (Recall = 0.92) in predicting OED progression, outperforming other grading systems (Binary: AUROC = 0.72, Recall = 0.85). Survival analyses showed the prognostic value of our OMTscore (C-index = 0.60, p = 0.02), compared to WHO (C-index = 0.64, p = 0.003) and binary grades (C-index = 0.65, p < 0.001). Nuclear analyses elucidated the presence of peri-epithelial and intra-epithelial lymphocytes in highly predictive patches of transforming cases ( p < 0.001). This is the first study to propose a completely automated, explainable, and externally validated algorithm for predicting OED transformation. Our algorithm shows comparable-to-human-level performance, offering a promising solution to the challenges of grading OED in routine clinical practice.

oncology
Prognosis Methylation of p 16 CpG Island Associated with Malignant Progression of Oral Epithelial Dysplasia : A Prospective Cohort Study

Jie Cao,Jing Zhou,Yan Gao,Liankun Gu,Huanxin Meng,Hongwei Liu,Dajun Deng

2009-01-01

Abstract:Purpose: Inactivation of p16 gene by CpG methylation is a frequent event in oral epithelial dysplasia. To investigate the predictive value of p16 methylation on malignant potential in oral epithelial dysplasia, we carried out the prospective cohort study. Experimental Design: One hundred one patients with histologically confirmed mild or moderate oral epithelial dysplasia were included in the present cohort study. p16 Methylation status of the oral epithelial dysplasia lesions from 93 cases was obtained by methylation-specific PCR. Progression of the oral epithelial dysplasia lesions was examined in 78 cases histologically during a 45.8 months follow-up period. The association between p16 methylation and progression of oral epithelial dysplasia was analyzed. Results: Of the 93 enrolled cases, 15 cases were lost during the follow-up because of changes of contact information, with a compliance of 83.9%. p16 Methylation was detectable in oral epithelial dysplasia lesions from 32 (41.0%) of 78 enrolled patients. Oral epithelial dysplasia–related squamous cell carcinomas were observed in 22 patients (28.2%) during the follow-up. Rate of progression to oral cancer in patients with the p16-methylated oral epithelial dysplasia was significantly higher than that with the p16-unmethylated oral epithelial dysplasia (43.8% versus 17.4%; adjusted odds ratio, 3.7; P = 0.013), especially for patients at the baseline age of ≥60 years (adjusted odds ratio, 12.0; P = 0.003) and patients with moderate oral epithelial dysplasia (adjusted odds ratio, 15.6; P = 0.022). The overall sensitivity and specificity of prediction of malignant transformation of oral epithelial dysplasia by p16 methylation were 63.6% and 67.9%, respectively. Conclusion: p16 Methylation was correlated with malignant transformation of oral epithelial dysplasia and is a potential biomarker for prediction of prognosis of mild or moderate oral epithelial dysplasia. (Clin Cancer Res 2009;15(16):5178–83) Leukoplakia is the most common oral precancerous lesion (1). About 8% of oral leukoplakia will progress to oral squamous cell carcinoma because about 17% to 25% of the leukoplakia lesions contain oral epithelial dysplasia (2, 3). Current diagnosis of oral epithelial dysplasia is based primarily on morphologic criteria (4). It is virtually impossible to identify a person with oral epithelial dysplasia at high risk for developing oral cancer on histopathologic grounds alone. A practical biomarker is not presently available for clinical management of oral epithelial dysplasia (5). Inactivation of the p16 (CDKN2A) gene is a frequent event in oral epithelial dysplasia and might play an important role in oral carcinogenesis (6). P16 protein is a cell cycle regulator involved in the inhibition of G1 phase progression (7). Methylation of CpG islands of p16 gene silences its transcription (8). Aberrant inactivation of p16 gene by methylation is an early frequent event in multiple human cancers, including oral squamous cell carcinomas and its precancerous oral epithelial dysplasia lesions (9–13). In nested case-control studies, it was observed that p16 methylation was Authors' Affiliations: Peking University School and Hospital of Stomatology, and Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Aetiology, Peking University School of Oncology, Beijing Cancer Hospital/Institute, Beijing, China Received 3/5/09; revised 4/3/09; accepted 4/16/09; published OnlineFirst 8/11/09. Grant support: National Basic Research Program of China (2005CB 522403) andCapital Program forDevelopmentofHealthSciences (grant 434;D.Deng). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Note: Supplementary data for this article are available at Clinical Cancer Research Online (http://clincancerres.aacrjournals.org/). Requests for reprints: Hongwei Liu, Department of Oral Medicine, Peking University School of Stomatology, Beijing 100081, China. E-mail: hongweil@ bjmu.edu.cn or Dajun Deng, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Aetiology, PekingUniversity School of Oncology, Beijing Cancer Hospital/Institute, Beijing, 100142, China. Phone: 8610-88196752; Fax: 8610-88122437; E-mail: dengdajun@ bjmu.edu.cn. F 2009 American Association for Cancer Research. doi:10.1158/1078-0432.CCR-09-0580 5178 Clin Cancer Res 2009;15(16) August 15, 2009 www.aacrjournals.org Research. on May 1, 2017. © 2009 American Association for Cancer clincancerres.aacrjournals.org Downloaded from Published OnlineFirst August 11, 2009; DOI: 10.1158/1078-0432.CCR-09-0580
Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta‐analysis of malignant transformation rate by subtype

Oreste Iocca,Thomas P. Sollecito,Faizan Alawi,Gregory S. Weinstein,Jason G. Newman,Armando De Virgilio,Pasquale Di Maio,Giuseppe Spriano,Simón Pardiñas López,Rabie M. Shanti

DOI: https://doi.org/10.1002/hed.26006

2019-12-05

Head and Neck

Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Importance</h3><p>Potentially malignant disorders of the oral cavity (OPMD) are a heterogeneous group of lesions associated with a variable risk of malignant transformation (MT) to invasive cancer. Leukoplakia (LE), lichen planus (LP), oral lichenoid lesions (OLL), oral erythroplakia (OE), oral submucous fibrosis (OSF), and proliferative verrucous leukoplakia (PVL) are among the most common of these lesions. Oral dysplasia is a mucosal area characterized by cellular and architectural derangement, which may be associated with OPMDs or not.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>To define the MT rate of OPMDs and the risk of development into cancer of mild vs moderate/severe oral dysplasia. This in order to implement adequate follow‐up strategies and treatment decisions.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study design</h3><p>We performed a systematic review and meta‐analysis on studies reporting the MT rates of OPMDs and oral dysplasia. Ninety‐two studies were included for the analysis. Cumulative rates were reported for OPMDs overall and as a subgroup, a comparison was made of mild vs moderate/severe dysplasia. Meta‐regression on OPMD and year of publication was also performed.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Main outcome and measures</h3><p>Overall MT rates of OPMDs and odds ratio of MT of mild vs moderate/severe dysplasia.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Overall MT rate across all OPMD groups was 7.9% (99% confidence interval [CI] 4.9%‐11.5%). MT rates of the specific OPMD subgroups were as follows: LP 1.4% (99% CI 0.9%‐1.9%), LE 9.5 (5.9%‐14.00%), OLL 3.8% (99% CI 1.6%‐7.00%), OSF 5.2% (99% CI 2.9%‐8.00%), OE 33.1% (99% CI 13.6%‐56.1%), and PVL 49.5% (99% CI 26.7%‐72.4%). Regarding the dysplasia grades comparison, the meta‐analysis showed that moderate/severe dysplasia is meaningfully associated to a much greater risk of MT compared to mild dysplasia with an odds ratio of 2.4 (99% CI 1.5‐3.8). Heterogeneity was not significant. Annual MT rates were approximated based on the average follow‐up as reported in the various subgroups. Lichen planus had an annual MT of 0.28%, OLL of 0.57%, leukoplakia of 1.56%, PVL of 9.3%, and OSF of 0.98%. Mild dysplasia had an annual MT of 1.7%, while severe dysplasia of 3.57%. Meta‐regression showed a significant negative correlation of PVL MT rate and year of the study (<i>P</i> value <.001). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions and relevance</h3><p>OPMDs and oral dysplasia are relatively common conditions that general practitioners, head and neck, and oral medicine specialists, face in their everyday practice. Our analysis confirms the significant risk of MT of these lesions, although variable among the subgroups. Moderate/severe dysplasia bears a much higher risk of cancer evolution than mild dysplasia. It is important to raise public health awareness on the MT rates of these conditions, at the same time efficacious communication with the patient is of utmost importance. This, coupled with strict follow‐up measures and optimal treatment strategies, would help in reducing the transformation of these oral conditions into invasive cancer.</p></section>

English Else
Abstract #1339: Methylation of P16 CpG Island Associated with Malignant Transformation of Oral Epithelial Dysplasia: a Prospective Cohort Study

Jie Cao,Guoquan Yan,Jing Zhou,Huifeng Wu,Dajun Deng

IF: 11.2

2009-01-01

Cancer Research

Abstract:Background: Identification of malignant potential of oral epithelial dysplasia (OED) is virtually impossible on histopathological grounds alone. Inactivation of p16 gene by CpG methylation is an early frequent event during carcinogenesis. To investigate predictive value of p16 methylation on malignant potential of OED, we carried out a prospective cohort study. Methods: 101 patients with histologically proven mild or moderate OED were included in the present study. Baseline information of p16 methylation of the OED lesions from 93 cases was obtained by methylation-specific PCR. The average followup time was 45.8 months. Progression of the OED lesions was examined histologically during the double-blind followup survey, with the compliance of 83.9% (78/93). SPSS13.0 software was used to do univariate and multivariate analysis. All P-values were two-sided. Results: p16 methylation was detectable in OED lesions from 32 of 78 (41.0%) enrolled patients. OED related squamous cell carcinomas were observed in 22 patients (28.2%) during the followup histologically. Canceration rate (43.8%, 14/32) in patients with the p16 -methylated OED was significant higher than that (17.4%, 8/46) in cases with the p16 -unmethylated OED (odds ratio [OR] =3.7; adjusted P =0.013), especially for patients at the baseline age of more than 60 yrs (OR=12.0; P p16 methylation were 63.6% (14/22) and 67.9% (38/56), respectively. Conclusion: p16 methylation was correlated with canceration of OED independently and a potential biomarker for prediction of malignant transformation of mild or moderate OED. Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 1339.

A local tournament contains a vertex whose out-arcs are g-pancyclic

Potential Immunohistochemical Biomarkers for Grading Oral Dysplasia: A Literature Review

Recommendations for Research to Develop a Patient‐Centered Clinical Follow‐Up Protocol for Oral Epithelial Dysplasia

Recent trends in predictive biomarkers for determining malignant potential of oral potentially malignant disorders

The Impact of Histopathological Features on the Prognosis of Oral Squamous Cell Carcinoma: A Comprehensive Review and Meta-Analysis

Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases

An Update on the Use of Artificial Intelligence in Digital Pathology for Oral Epithelial Dysplasia Research

Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis

P16 Methylation As an Early Predictor for Cancer Development from Oral Epithelial Dysplasia: A Double-blind Multicentre Prospective Study.

Transcriptional analysis highlights three distinct immune profiles of high-risk oral epithelial dysplasia

Longitudinal Study of Oral Precancerous Lesions: Transformation Rate and Predictive Markers for Malignancy

Epigenetics in the diagnosis and prognosis of head and neck cancer: A systematic review

Emerging histopathologic markers in early-stage oral tongue cancer: A systematic review and meta-analysis

Evaluation of Metabolomics as Diagnostic Targets in Oral Squamous Cell Carcinoma: A Systematic Review

Identification of inflammatory mediators associated with metastasis of oral squamous cell carcinoma in experimental and clinical studies: systematic review

Using a Terrorist Attack to Estimate the Effect of Police on Crime

Artificial Intelligence Applications in Oral Cancer and Oral Dysplasia

A fully automated and explainable algorithm for predicting malignant transformation in oral epithelial dysplasia

Prognosis Methylation of p 16 CpG Island Associated with Malignant Progression of Oral Epithelial Dysplasia : A Prospective Cohort Study

Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta‐analysis of malignant transformation rate by subtype

Abstract #1339: Methylation of P16 CpG Island Associated with Malignant Transformation of Oral Epithelial Dysplasia: a Prospective Cohort Study